Influence of Selective Melanocortin-4 Receptor Antagonist HS014 on Hypersensitivity After Nervous System Injuries in a Model of Rat Neuropathic Pain: A Narrative Review of the Literature

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Sep 29

PMID 34584810

Citations 1

Authors

Narmeen Shikdar

Faisal AlGhamdi

Affiliations

Soon will be listed here.

Abstract

Background And Objective: The melanocortin-4 (MC4) receptor has been evaluated as a possible new therapeutic for neuropathic pain treatment. The purpose of this review article was to review and evaluate all recent in vivo studies on the effect of the MC4 receptor antagonist HS014 on rat hypersensitivity caused by neuropathic pain.

Methods: An electronic search was carried out using Scopus, Web of Science, PubMed, and Google Scholar. The following inclusion criteria were used: rat models of neuropathic pain-induced hypersensitivity, with investigated effects of the selective antagonist HS014. The included duration of the search was within the last ten years. Data regarding HS014, neuropathic pain model, post-treatment administration time and dose (days post-injury), behavior assessment assays, treatment frequency, and route of delivery were collected and subjected descriptively as complementary data in this narrative review.

Results: This narrative review included four papers that fulfilled the eligibility criteria. The findings demonstrate that as compared to vehicle-treated rats, administration of the MC4 receptor antagonist HS014 remarkably raised paw withdrawal threshold (PWT) in three studies and heat withdrawal latency in four studies among rat models subjected to neuropathic pain.

Conclusions: In rat neuropathic pain models, the MC4 receptor antagonist HS014 is helpful in reducing hypersensitivity. However, further studies are needed to determine the ideal treatment dosage and timing. In addition, further investigations are required for the role of this selective receptor antagonist (HS014) and compared with other types of MC4 receptors in neuropathic pain in humans.

Citing Articles

Case report: Nerve fiber regeneration in children with melanocortin 4 receptor gene mutation related obesity treated with semaglutide.

Gad H, Mohammed I, Dauleh H, Pasha M, Al-Barazenji T, Hussain K Front Endocrinol (Lausanne). 2024; 15:1385463.

PMID: 38974580 PMC: 11227249. DOI: 10.3389/fendo.2024.1385463.

References

Ye D, Liu C, Liu T, Tian X, Xiang H . Motor cortex-periaqueductal gray-spinal cord neuronal circuitry may involve in modulation of nociception: a virally mediated transsynaptic tracing study in spinally transected transgenic mouse model. PLoS One. 2014; 9(2):e89486. PMC: 3929690. DOI: 10.1371/journal.pone.0089486. View

Zhao Y, Xin Y, Chu H . MC4R Is Involved in Neuropathic Pain by Regulating JNK Signaling Pathway After Chronic Constriction Injury. Front Neurosci. 2019; 13:919. PMC: 6746920. DOI: 10.3389/fnins.2019.00919. View

Adan R, Gispen W . Melanocortins and the brain: from effects via receptors to drug targets. Eur J Pharmacol. 2000; 405(1-3):13-24. DOI: 10.1016/s0014-2999(00)00537-9. View

Zimmermann E, KRIVOY W . Antagonism between morphine and the polypeptides ACTH, ACTH1-24 and beta-MSH in the nervous system. Prog Brain Res. 1973; 39:383-94. DOI: 10.1016/S0079-6123(08)64094-7. View

Chu H, Xia J, Yang Z, Gao J . Melanocortin 4 receptor induces hyperalgesia and allodynia after chronic constriction injury by activation of p38 MAPK in DRG. Int J Neurosci. 2011; 122(2):74-81. DOI: 10.3109/00207454.2011.630542. View

Li Z, Liu B, He Z, Xiang H . Melanocortin-4 receptor regulation of pain. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(10 Pt A):2515-2522. DOI: 10.1016/j.bbadis.2017.05.021. View

Xia Y, Wikberg J, Chhajlani V . Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport. 1995; 6(16):2193-6. DOI: 10.1097/00001756-199511000-00022. View

Zvejniece L, Muceniece R, Krigere L, Dambrova M, Klusa V . The differential influences of melanocortins on nociception in the formalin and tail flick tests. Pharmacol Biochem Behav. 2006; 85(2):287-91. DOI: 10.1016/j.pbb.2006.08.001. View

Nagakura Y, Nagaoka S, Kurose T . Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models. Int J Mol Sci. 2021; 22(12). PMC: 8232571. DOI: 10.3390/ijms22126406. View

10.

Delaney A, Keighren M, Fleetwood-Walker S, Jackson I . Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin. PLoS One. 2010; 5(9):e12498. PMC: 2938350. DOI: 10.1371/journal.pone.0012498. View

11.

Starowicz K, Bilecki W, Sieja A, Przewlocka B, Przewlocki R . Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats. Neurosci Lett. 2004; 358(2):79-82. DOI: 10.1016/j.neulet.2003.12.096. View

12.

Pan X, Song Y, Liu C, Xiang H, Lu C . Melanocortin-4 receptor expression in the rostral ventromedial medulla involved in modulation of nociception in transgenic mice. J Huazhong Univ Sci Technolog Med Sci. 2013; 33(2):195-198. DOI: 10.1007/s11596-013-1096-9. View

13.

Bertolini A, Poggioli R, Ferrari W . ACTH-induced hyperalgesia in rats. Experientia. 1979; 35(9):1216-7. DOI: 10.1007/BF01963298. View

14.

Zhang Y, Jiang D, Li H, Sun Y, Jiang X, Gong S . Melanocortin type 4 receptor-mediated inhibition of A-type K current enhances sensory neuronal excitability and mechanical pain sensitivity in rats. J Biol Chem. 2019; 294(14):5496-5507. PMC: 6462507. DOI: 10.1074/jbc.RA118.006894. View

15.

Caruso V, Lagerstrom M, Olszewski P, Fredriksson R, Schioth H . Synaptic changes induced by melanocortin signalling. Nat Rev Neurosci. 2014; 15(2):98-110. DOI: 10.1038/nrn3657. View

16.

Arout C, Caldwell M, Rossi G, Kest B . Spinal and supraspinal N-methyl-D-aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia. Physiol Behav. 2015; 147:364-72. DOI: 10.1016/j.physbeh.2015.05.006. View

17.

Shen Y, Fu W, Cheng E, Fu A, Ip N . Melanocortin-4 receptor regulates hippocampal synaptic plasticity through a protein kinase A-dependent mechanism. J Neurosci. 2013; 33(2):464-72. PMC: 6704894. DOI: 10.1523/JNEUROSCI.3282-12.2013. View

18.

Ercil N, Galici R, Kesterson R . HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice. Psychopharmacology (Berl). 2005; 180(2):279-85. DOI: 10.1007/s00213-005-2166-x. View

19.

Bertorelli R, Fredduzzi S, Tarozzo G, Campanella M, Grundy R, Beltramo M . Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain. Behav Brain Res. 2004; 157(1):55-62. DOI: 10.1016/j.bbr.2004.06.008. View

20.

Tao Y . The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev. 2010; 31(4):506-43. PMC: 3365848. DOI: 10.1210/er.2009-0037. View